Skip to main content

Table 4 RT characteristics of the 23 patients with 36 sites treated with hypofractionated schemes of 36 Gy in 12 fractions

From: Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era

RT target site (patient ID)

Volume, cm3

OARs

GTV

CTV

Head and neck

 

Parotid gland, Dmean, Gy

Larynx, Dmean, Gy

Spinal cord, Dmax, Gy

 Cervical lymph node (P4)

NA

10.9

4.0

2.7

7.4

 Cervical lymph node (P11)

2.3

216.9

17.8

15.7

14.4

 Nasal cavity (P8)

128.3

331.9

13.2

9.7

16.7

 Maxillary sinus (P5)

5.5

85.5

5.8

17.4

9.9

 Masseter (P18)

29.6

88.5

30.4

6.5

14.2

Thorax

Lung, V20, %

Heart, Dmean, Gy

Spinal cord, Dmax, Gy

 Axilla (P2)

19.8

118.9

0.7

0.2

4.2

 Axilla (P6)

6.6

164.5

2.4

0.2

6.4

 Axilla (P20)

NA

95.8

0.2

0.3

0.5

 Axilla (P20)

NA

93.6

0.1

0.1

0.5

 Mediastinum (P3)

24.6

283.3

2.2

9.5

14.7

 Mediastinum (P4)

NA

65.1

0.2

0.3

16.8

 Mediastinum (P12)

18.6

157.2

14.2

5.2

17.3

 Mediastinum (P12)

80.1

258.1

6.6

14.4

21.3

 Mediastinum (P15)

151.3

253.9

7.6

5.3

17.3

 Mediastinum (P19)

13.5

343.7

27.8

16.6

19.6

 Mediastinum (P20)

172.3

463.9

22.5

17.0

33.4

 Mediastinum (P21)

2.8

51.4

2.9

0.3

15.1

 Mediastinum (P22)

62.8

337.1

13.0

8.7

18.5

 Arm (P4)

2.7

119.9

NA

1.1

2.5

 Breast (P17)

191.5

781.4

6.9

1.1

18.7

Abdomen

Kidney, V20, %

Small intestine, Dmax, Gy

Spinal cord, Dmax, Gy

 Spleen (P4)

12

172.4

4.3

6.5

9.8

 Psoas major (P4)

26.7

137.4

NA

35.8

7.7

 Buttock (P4)

9.6

233.3

NA

24.8

7.5

 Back (P9)

191.9

692.6

23.3

30.9

24.0

 Mesentery (P10)

86.7

258.8

2.2

38.9

15.1

 Stomach (P16)

20.6

287.5

8.5

27.1

18.4

 Retroperitoneum (P7)

95.7

685.6

18.6

37.7

19.5

 Retroperitoneum (P13)

38.4

461.0

7.5

39.6

23.1

 Retroperitoneum (P18)

116.3

225.0

NA

22.0

1.5

 Retroperitoneum (P18)

8.0

155.8

6.2

39.2

15.9

Pelvic

Bladder, Dmean, Gy/V30, %

Head of femur, Dmax, Gy

Rectum, Dmean, Gy/V30, %

 Prostate and bladder (P1)

134.7

512.6

29.1/24.1

19.3

23.6/23.6

 Rectum and prostate (P14)

55.1

NA

16.2/5.2

13.8

23.5/32.6

 Testicle (P7)

NA

145.1

5.9/NA

21.0

4.0/NA

 Uterus (P11)

12.6

NA

5.1/1.9

8.7

3.30/NA

 Groin lymph node (P8)

19.5

99.9

0.4/NA

1.5

0.7/NA

 Groin lymph node (P18)

6.5

54.0

0.8/NA

20.0

1.8/NA

  1. Abbreviations: RT radiotherapy, Dmean mean dose, Dmax maximal dose, V20 percentage volumes receiving 20 Gy, V30 percentage volumes receiving 30 Gy